Pivot Bio Status
The company raised an estimated $70 million of Series B venture funding from lead investor Breakthrough Energy Ventures on September 26, 2018, putting the company's pre-money valuation at $130 million. Temasek Holdings and Tekfen Ventures also participated. The company intends to use the funds to strengthen the commercial launch of nitrogen-producing microbes for U.S. corn farmers, conduct research and development activities for its second-generation product, a seed treatment option, as well as introduce products beyond the U.S. in markets such as Brazil, Argentina and Canada.
Add a review